New Gene Linked to Hereditary Optic Atrophy Offers Hope for Diagnosis and Treatment
Table of Contents
A breakthrough revelation by researchers in Austria has identified a previously unkown genetic cause of hereditary optic atrophy, a debilitating degenerative disease leading to vision loss. The findings, published in February 2025 in Genetics in Medicine, pave the way for improved genetic diagnosis and targeted research into potential therapies.
unraveling the Genetic mystery
The investigation began with a comprehensive genetic analysis of a large Austrian family spanning three generations, where seven individuals were affected by optic atrophy. Genome-wide sequencing pinpointed a previously undescribed variant within the PPIB gene (peptidylprolyl isomerase B). This gene provides instructions for creating an enzyme crucial for ensuring proteins fold into their correct shapes and for breaking down misfolded proteins.
Researchers found that this specific gene variant disrupts the function of mitochondria – frequently enough referred to as the “power plants” of cells – in affected individuals’ cells. Impaired mitochondrial function is a common thread in many known forms of hereditary optic atrophy. further analysis of existing genomic data revealed the same genetic mutation in twelve additional individuals from eight separate families.
“We have thus succeeded in describing the PPIB gene as a new optic atrophy gene,” stated a study leader from the Center for Anatomy and Cell Biology at the Medical University of Vienna. “The identification of this genetic variant creates the possibility of a genetic diagnosis, which has been lacking in many cases,” added a co-study leader from the Department of Ophthalmology at the Medical University of Graz. This diagnostic capability is critical for providing informed guidance to affected families and tailoring medical care to individual needs.
Did you know?-Hereditary optic atrophy affects approximately 1 in 50,000 people worldwide. Early diagnosis is crucial, but can be challenging due to the genetic complexity of the disease.
The Impact of Optic Atrophy and the Promise of Genetic Insights
Optic atrophy is characterized by the progressive degeneration of the optic nerve, ultimately damaging the retinal ganglion cells responsible for transmitting visual information to the brain. Early symptoms frequently enough include reduced visual acuity, difficulty perceiving colors, and defects in central vision. The disease can be inherited, with approximately 20 known genetic forms, many linked to mitochondrial dysfunction.
Despite advancements in genetic diagnostics, the underlying genetic cause remains elusive in around 60 percent of those affected. This study, a collaborative effort between multiple departments at the Medical University of vienna and the University Eye Clinic at the Medical University of Graz, directly addresses this gap by identifying the PPIB gene’s role.
Future research will focus on understanding precisely how the PPIB variant impacts cellular metabolism and whether additional genetic alterations within this gene are associated with the advancement of optic atrophy. .
The research team’s discovery represents a significant step forward in understanding and ultimately combating this devastating disease.
Pro tip:-Genetic counseling is recommended for families with a history of optic atrophy. Counselors can explain inheritance patterns and discuss available testing options.
Why: Researchers sought to identify the genetic cause of hereditary optic atrophy to improve diagnosis and treatment.
Who: The study was led by researchers at the Medical University of Vienna and the University Eye Clinic at the Medical University of Graz in Austria. Families with a history of the disease were involved.
What: A previously unknown genetic variant in the PPIB gene was identified as a cause of hereditary optic atrophy. This variant disrupts mitochondrial function.
How did it end?: The study concluded with the identification of the PPIB gene as a new optic atrophy gene, opening avenues for genetic diagnosis and future research into therapies. The research team plans to further investigate the impact of the PPIB variant on cellular metabolism.
